Outcomes in preterm infants who received a lipid emulsion with fish oil: An observational study
Journal of Parenteral and Enteral Nutrition · 2023
DOI: 10.1002/jpen.2464 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Parenteral and Enteral Nutrition, 2023. Verfasst von Esther S Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Children's Discovery and Innovation Institute, UCLA Mattel Children's Hospital, David Geffen School of Medicine, University…. Hauptthemen laut MEDLINE: Fish Oils, Parenteral Nutrition. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, NICHD NIH HHS.
Themen: Neonatologie
Abstract (Originalsprache)
Background
100% soybean oil emulsions (SO100) are associated with poor docosahexaenoic acid (DHA) and arachidonic acid (ARA) status in extremely low birth weight (ELBW) infants. A multi‐oil emulsion with 15% fish oil (FO15) contains more DHA and ARA than SO100. This study compares clinical outcomes, namely growth and fatty acids, in ELBW infants who received S0100 or FO15.
Methods
This observational study included ELBW infants born between 2014 and 2019 who received SO100 or FO15 for >7 days. Gas chromatography/mass spectrometry was used to measure erythrocyte fatty acids.
Results
The mean ± SD gestational age was 27 ± 3 and 26 ± 2 weeks for SO100 ( n = 43) and FO15 ( n = 43), respectively ( P = 0.2). DHA (−0.3 ± 0.10% per week, P = 0.026, for FO15 vs −0.2 ± 0.05% per week, P < 0.001, for SO100) and ARA (−0.8 ± 0.21% per week for FO15 vs −0.9 ± 0.17% per week for SO100; P < 0.001 for both) declined in both groups with no difference between groups ( P interaction > 0.7 for both). After controlling for days to reach full feeds, the mean difference in weight z score trajectories was similar (Est = −0.08; 95% CI, −0.82 to 0.04; P = 0.2), and SO100 was associated with a nonsignificant increased odds for cholestasis (odds ratio, 3.1; 95% CI, 0.96–10.2; P = 0.059). There was no difference in other clinical comorbidities.
Conclusions
In comparison with ELBW infants who received SO100, infants who received FO15 still demonstrated a decline in DHA and ARA. Growth and other clinical outcomes were unchanged.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Children's Discovery and Innovation Institute, UCLA Mattel Children's Hospital, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
- David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
- Department of Medicine, Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
ORCID-Profile: Kara L Calkins
Förderung
- NCATS NIH HHS
- NICHD NIH HHS
Zitieren
APA
Kim, E. S., Lee, L. J., Romero, T., & Calkins, K. L. (2023). Outcomes in preterm infants who received a lipid emulsion with fish oil: An observational study. Journal of Parenteral and Enteral Nutrition. https://doi.org/10.1002/jpen.2464
Vancouver
Kim ES, Lee LJ, Romero T, Calkins KL. Outcomes in preterm infants who received a lipid emulsion with fish oil: An observational study. Journal of Parenteral and Enteral Nutrition. 2023. doi:10.1002/jpen.2464
BibTeX
@article{Kim2023,
author = {Kim, Esther S and Lee, Lauren J and Romero, Tahmineh and Calkins, Kara L},
title = {Outcomes in preterm infants who received a lipid emulsion with fish oil: An observational study},
journal = {Journal of Parenteral and Enteral Nutrition},
year = {2023},
doi = {10.1002/jpen.2464}
}
EUVIMED